161 related articles for article (PubMed ID: 32117782)
1. PELP1 Suppression Inhibits Gastric Cancer Through Downregulation of c-Src-PI3K-ERK Pathway.
Yan H; Sun Y; Wu Q; Wu Z; Hu M; Sun Y; Liu Y; Ma Z; Liu S; Xiao W; Liu F; Ning Z
Front Oncol; 2019; 9():1423. PubMed ID: 32117782
[No Abstract] [Full Text] [Related]
2. PELP1 is a novel oncogene in gastric tumorigenesis and negatively regulated by miR-15 family microRNAs.
Ma C; Miao C; Wang C; Song F; Luo M
Cancer Biomark; 2019; 26(1):1-9. PubMed ID: 31322541
[TBL] [Abstract][Full Text] [Related]
3. PELP1 suppression inhibits colorectal cancer through c-Src downregulation.
Ning Z; Zhang Y; Chen H; Wu J; Song T; Wu Q; Liu F
Oxid Med Cell Longev; 2014; 2014():193523. PubMed ID: 24967003
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.
Rajhans R; Nair S; Holden AH; Kumar R; Tekmal RR; Vadlamudi RK
Cancer Res; 2007 Jun; 67(11):5505-12. PubMed ID: 17545633
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CRNDE is a novel tumor promoter by modulating PI3K/AKT signal pathways in human gastric cancer.
Du DX; Lian DB; Amin BH; Yan W
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5392-5398. PubMed ID: 29243780
[TBL] [Abstract][Full Text] [Related]
6. FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway.
Huang T; Liu D; Wang Y; Li P; Sun L; Xiong H; Dai Y; Zou M; Yuan X; Qiu H
Cell Physiol Biochem; 2018; 50(4):1332-1345. PubMed ID: 30355943
[TBL] [Abstract][Full Text] [Related]
7. Altered Expression of
Englert-Golon M; Andrusiewicz M; Żbikowska A; Chmielewska M; Sajdak S; Kotwicka M
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207568
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
[TBL] [Abstract][Full Text] [Related]
9. High expression of SMARCE1 predicts poor prognosis and promotes cell growth and metastasis in gastric cancer.
Liu H; Zhao YR; Chen B; Ge Z; Huang JS
Cancer Manag Res; 2019; 11():3493-3509. PubMed ID: 31118775
[No Abstract] [Full Text] [Related]
10. Downregulation of PSCA promotes gastric cancer proliferation and is related to poor prognosis.
Xu LP; Qiu HB; Yuan SQ; Chen YM; Zhou ZW; Chen YB
J Cancer; 2020; 11(9):2708-2715. PubMed ID: 32201541
[No Abstract] [Full Text] [Related]
11. PELP1/MNAR suppression inhibits proliferation and metastasis of endometrial carcinoma cells.
Wan J; Li X
Oncol Rep; 2012 Dec; 28(6):2035-42. PubMed ID: 22992812
[TBL] [Abstract][Full Text] [Related]
12. Expression of estrogen receptors, PELP1, and SRC in human spermatozoa and their associations with semen quality.
Skibińska I; Andrusiewicz M; Jendraszak M; Żbikowska A; Jędrzejczak P; Kotwicka M
Hum Cell; 2023 Mar; 36(2):554-567. PubMed ID: 36577884
[TBL] [Abstract][Full Text] [Related]
13. Functional implications of altered subcellular localization of PELP1 in breast cancer cells.
Vadlamudi RK; Manavathi B; Balasenthil S; Nair SS; Yang Z; Sahin AA; Kumar R
Cancer Res; 2005 Sep; 65(17):7724-32. PubMed ID: 16140940
[TBL] [Abstract][Full Text] [Related]
14. PELP1 and SRC kinase as important molecules in the estrogen-mediated pathway in human testis and epididymis.
Skibińska I; Andrusiewicz M; Jendraszak M; Żbikowska A; Żaba C; Kotwicka M
Acta Biochim Pol; 2023 May; 70(2):447-456. PubMed ID: 37159918
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of proline-, glutamic acid- and leucine-rich protein PELP1 in non-small cell lung cancer.
Słowikowski BK; Gałęcki B; Dyszkiewicz W; Jagodziński PP
Biomed Pharmacother; 2015 Jul; 73():97-101. PubMed ID: 26211588
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HOXA11-AS promotes migration and invasion through modulating miR-148a/WNT1/β-catenin pathway in gastric cancer.
Guo T; Yuan X; Liu DF; Peng SH; Xu AM
Neoplasma; 2020 May; 67(3):492-500. PubMed ID: 32009419
[TBL] [Abstract][Full Text] [Related]
17. MiR-1298 expression correlates with prognosis and inhibits cell proliferation and invasion of gastric cancer.
Qiu ZK; Liu N; Zhao SF; Ding AP; Cheng G; Qiu WS; Qi WW
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1672-1679. PubMed ID: 29630111
[TBL] [Abstract][Full Text] [Related]
18. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
Zeng B; Shi W; Tan G
BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
[TBL] [Abstract][Full Text] [Related]
19. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
20. Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.
Manavathi B; Nair SS; Wang RA; Kumar R; Vadlamudi RK
Cancer Res; 2005 Jul; 65(13):5571-7. PubMed ID: 15994929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
